The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Drug treatment of epilepsy in adults
Abstract
Epilepsy is a serious, potentially life shortening brain disorder, the symptoms of which can be successfully treated in most patients with one or more antiepileptic drug. About two in three adults with new onset epilepsy will achieve lasting seizure remission on or off these drugs, although around half will experience mild to moderately severe adverse effects. Patients with epilepsy, especially the 20-30% whose seizures are not fully controlled with available drugs (drug resistant epilepsy), have a significantly increased risk of death, as well as psychiatric and somatic comorbidities, and adverse effects from antiepileptic drugs. Newer drugs have brought more treatment options, and some such as levetiracetam cause fewer drug interactions and less hypersensitivity than older ones. However, they do not reduce the prevalence of drug resistant epilepsy or prevent the development of epilepsy in patients at high risk, such as those with a traumatic brain injury. The development of antiepileptic drugs urgently needs to be revitalized so that we can discover more effective antiseizure drugs for the treatment of drug resistant epilepsy, including catastrophic forms. Antiepileptogenic agents to prevent epilepsy before the first seizure in at risk patients and disease modifying agents to control ongoing severe epilepsy associated with progressive underlying disease are also needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
WOTHERSPOON, A. (1991) · The Lancet · doi:10.1016/0140-6736(91)92035-z · Cited by 1,866
Estimation of the burden of active and life-time epilepsy: a meta-analytic approach
Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W., & Newton, C. R. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02481.x · Cited by 1,447
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1430 · Cited by 1,239
Patsalos, P. N., Berry, D. J., Bourgeois, B. F. D., Cloyd, J. C., Glauser, T. A., Johannessen, S. I., Leppik, I. E., Tomson, T., & Perucca, E. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01561.x · Cited by 1,156
Mattson, R. H., Cramer, J. A., Collins, J. F., Smith, D. B., Delgado-Escueta, A. V., Browne, T. R., Williamson, P. D., Treiman, D. M., McNamara, J. O., McCutchen, C. B., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507183130303 · Cited by 1,138
HOW COMMON ARE THE “COMMON” NEUROLOGIC DISORDERS?
Kaplin, A. I., & Williams, M. (2007) · Neurology · doi:10.1212/01.wnl.0000278071.91524.4d · Cited by 1,131
Psychiatric comorbidity in epilepsy: a population-based analysis
Tellez‐Zenteno, J. F., Patten, S. B., Jetté, N., Williams, J., & Wiebe, S. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01222.x · Cited by 1,113
Standards for epidemiologic studies and surveillance of epilepsy
Thurman, D. J., Beghi, E., Begley, C. E., Berg, A. T., Buchhalter, J. R., Ding, D., Hesdorffer, D. C., Hauser, W. A., Kazis, L., Kobau, R., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03121.x · Cited by 1,014
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60460-7 · Cited by 976
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60461-9 · Cited by 969
Patterns of treatment response in newly diagnosed epilepsy
Brodie, M. J., Barry, S. J. E., Bamagous, G. A., Norrie, J. D., & Kwan, P. (2012) · Neurology · doi:10.1212/wnl.0b013e3182563b19 · Cited by 931
Meador, K. J., Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70323-x · Cited by 834
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., & Vajda, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70107-7 · Cited by 751
Glauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Guerreiro, C., Kälviäinen, R., Mattson, R., French, J. A., Perucca, E., Tomson, T., et al. (2013) · Epilepsia · doi:10.1111/epi.12074 · Cited by 721
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Self-citationA systematic review of rapid diagnostic tests for the detection of tuberculosis infection
Dinnes, J., Deeks, J., Kunst, H., Gibson, A., Cummins, E., Waugh, N., Drobniewski, F., & Lalvani, A. (2007) · Health Technology Assessment · doi:10.3310/hta11030 · Cited by 666
Arroyo, S., Rumià, J., Martínez, I., & Ribalta, T. (1998) · PubMed · Cited by 652
Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma
Löscher, W., & Schmidt, D. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03024.x · Cited by 590
Self-citationValproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
Jentink, J., Loane, M. A., Dolk, H., Barisic, I., Garne, E., Morris, J. K., & de Jong-van den Berg, L. T. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907328 · Cited by 587
A systematic review and economic evaluation of statins for the prevention of coronary events
Ward, S., Lloyd Jones, M., Pandor, A., Holmes, M., Ara, R., Ryan, A., Yeo, W., & Payne, N. (2007) · Health Technology Assessment · doi:10.3310/hta11140 · Cited by 556
Key factors in the discovery and development of new antiepileptic drugs
Bialer, M., & White, H. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2997 · Cited by 542
Predictors of pharmacoresistant epilepsy
Hitiris, N., Mohanraj, R., Norrie, J., Sills, G. J., & Brodie, M. J. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.06.003 · Cited by 527
New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine
Rowan, A. J., Ramsay, R. E., Collins, J. F., Pryor, F., Boardman, K. D., Uthman, B. M., Spitz, M., Frederick, T., Towne, A., Carter, G. S., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167384.68207.3e · Cited by 509
Global disparities in the epilepsy treatment gap: a systematic review
Meyer, A.-C., Dua, T., Ma, J., Saxena, S., & Birbeck, G. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.09.064147 · Cited by 496
Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms
Schmidt, D., & Löscher, W. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.54904.x · Cited by 482
Self-citationComparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy
Brodie, M. J., Perucca, E., Ryvlin, P., Ben-Menachem, E., & Meencke, H.-J. (2007) · Neurology · doi:10.1212/01.wnl.0000252941.50833.4a · Cited by 467
Picot, M., Baldy‐Moulinier, M., Daurès, J., Dujols, P., & Crespel, A. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01579.x · Cited by 455
McIntyre, J., Robertson, S., Norris, E., Appleton, R., Whitehouse, W. P., Phillips, B., Martland, T., Berry, K., Collier, J., Smith, S., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66909-7 · Cited by 445
Marson, A., Jacoby, A., Johnson, A., Kim, L., Gamble, C., & Chadwick, D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66694-9 · Cited by 438
Patsalos, P. N., & Perucca, E. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00409-5 · Cited by 423
Shorvon, S., & Ferlisi, M. (2012) · Brain · doi:10.1093/brain/aws091 · Cited by 418
Löscher, W., & Brandt, C. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003046 · Cited by 414
Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study
Sillanpää, M., & Schmidt, D. (2006) · Brain · doi:10.1093/brain/awh726 · Cited by 414
Self-citationNonadherence to antiepileptic drugs and increased mortality: Findings from the RANSOM Study
Faught, E., Duh, M. S., Weiner, J. R., Guérin, A., & Cunnington, M. C. (2008) · Neurology · doi:10.1212/01.wnl.0000319693.10338.b9 · Cited by 411
Seizure Reduction and Quality of Life Improvements in People with Epilepsy
Birbeck, G. L., Hays, R. D., Cui, X., & Vickrey, B. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.32201.x · Cited by 395
Increased rate of major malformations in offspring exposed to valproate during pregnancy
Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., & Holmes, L. B. (2005) · Neurology · doi:10.1212/01.wnl.0000154516.43630.c5 · Cited by 390
Risk of Recurrent Seizures after Two Unprovoked Seizures
Hauser, W. A., Rich, S. S., Lee, J. R.-J., Annegers, J. F., & Anderson, V. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380704 · Cited by 387
Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study
Fazel, S., Wolf, A., Långström, N., Newton, C. R., & Lichtenstein, P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60899-5 · Cited by 383
Enzyme induction with antiepileptic drugs: Cause for concern?
Brodie, M. J., Mintzer, S., Pack, A. M., Gidal, B. E., Vecht, C. J., & Schmidt, D. (2013) · Epilepsia · doi:10.1111/j.1528-1167.2012.03671.x · Cited by 383
Self-citationRandomised study of antiepileptic drug withdrawal in patients in remission
MEDICALRESEARCHCOUNCILANTIEPILE (1991) · The Lancet · doi:10.1016/0140-6736(91)92856-w · Cited by 354
Development of new antiepileptic drugs: challenges, incentives, and recent advances
Perucca, E., French, J., & Bialer, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70215-6 · Cited by 339
Ryvlin, P., Cucherat, M., & Rheims, S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70193-4 · Cited by 338
The pharmacological treatment of epilepsy in adults
Perucca, E., & Tomson, T. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70047-3 · Cited by 334
Preventing and treating posttraumatic seizures: The human experience
Temkin, N. R. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.02005.x · Cited by 329
Kim, L. G., Johnson, T. L., Marson, A. G., & Chadwick, D. W. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70383-0 · Cited by 320
Quantifying the response to antiepileptic drugs: Effect of past treatment history
Schiller, Y., & Najjar, Y. (2008) · Neurology · doi:10.1212/01.wnl.0000286959.22040.6e · Cited by 313
Cockerell, O. C., Johnson, A. L., Sander, J. W. A. S., & Shorvon, S. D. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01075.x · Cited by 311
Battino, D., Tomson, T., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., Vajda, F., & EURAP Study Group (2013) · Epilepsia · doi:10.1111/epi.12302 · Cited by 298
Relapse following discontinuation of antiepileptic drugs: A meta‐analysis
Berg, A. T., & Shinnar, S. (1994) · Neurology · doi:10.1212/wnl.44.4.601 · Cited by 294
Long-Term Mortality in Childhood-Onset Epilepsy
Stockman, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2011.06.022 · Cited by 289
Tellez-Zenteno, J. F., Dhar, R., Hernandez-Ronquillo, L., & Wiebe, S. (2007) · Brain · doi:10.1093/brain/awl316 · Cited by 286
Engel, J., Jr., Thompson, P. M., Stern, J. M., Staba, R. J., Bragin, A., & Mody, I. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835ee5b8 · Cited by 283
The clinical impact of pharmacogenetics on the treatment of epilepsy
Löscher, W., Klotz, U., Zimprich, F., & Schmidt, D. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01716.x · Cited by 281
Self-citationTeratogenic effects of antiepileptic drugs
Tomson, T., & Battino, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70103-5 · Cited by 271
Harden, C. L., Meador, K. J., Pennell, P. B., Allen Hauser, W., Gronseth, G. S., French, J. A., Wiebe, S., Thurman, D., Koppel, B. S., Kaplan, P. W., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02129.x · Cited by 255
Privitera, M. D., Brodie, M. J., Mattson, R. H., Chadwick, D. W., Neto, W., Wang, S., & for the EPMN 105 Study Group (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00093.x · Cited by 249
Fracture Risk Associated with Use of Antiepileptic Drugs
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.18804.x · Cited by 241
Löscher, W., & Schmidt, D. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00607.x · Cited by 239
Self-citationHirtz, D., Berg, A., Bettis, D., Camfield, C., Camfield, P., Crumrine, P., Gaillard, W. D., Schneider, S., & Shinnar, S. (2003) · Neurology · doi:10.1212/01.wnl.0000033622.27961.b6 · Cited by 213
Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy
Reisinger, T. L., Newman, M., Loring, D. W., Pennell, P. B., & Meador, K. J. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.06.026 · Cited by 211
The somatic comorbidity of epilepsy: A weighty but often unrecognized burden
Gaitatzis, A., Sisodiya, S. M., & Sander, J. W. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03528.x · Cited by 210
Pharmacoresistance and the role of surgery in difficult to treat epilepsy
Wiebe, S., & Jette, N. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.181 · Cited by 207
Temporal patterns and mechanisms of epilepsy surgery failure
Najm, I., Jehi, L., Palmini, A., Gonzalez‐Martinez, J., Paglioli, E., & Bingaman, W. (2013) · Epilepsia · doi:10.1111/epi.12152 · Cited by 197
Treatment of epilepsy in adults: expert opinion, 2005
Karceski, S., Morrell, M. J., & Carpenter, D. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.06.001 · Cited by 194
Baulac, M., Brodie, M. J., Patten, A., Segieth, J., & Giorgi, L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70105-9 · Cited by 186
Drug treatment of epilepsy: Options and limitations
Schmidt, D. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.02.030 · Cited by 177
Self-citationHarden, C. L., Pennell, P. B., Koppel, B. S., Hovinga, C. A., Gidal, B., Meador, K. J., Hopp, J., Ting, T. Y., Hauser, W. A., Thurman, D., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02130.x · Cited by 170
Shorvon, S. D., Baulac, M., Cross, J. H., Trinka, E., Walker, M. C., & for the TaskForce on Status Epilepticus of the ILAE Commission for European Affairs (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01706_3.x · Cited by 166
Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy
Sillanpaa, M., & Schmidt, D. (2008) · Brain · doi:10.1093/brain/awn357 · Cited by 163
Self-citationBeghi, E., Gatti, G., Tonini, C., Ben-Menachem, E., Chadwick, D. W., Nikanorova, M., Gromov, S. A., Smith, P. E. M., Specchio, L. M., & Perucca, E. (2003) · Epilepsy Research · doi:10.1016/j.eplepsyres.2003.09.007 · Cited by 159
Bone health in people with epilepsy: Is it impaired and what are the risk factors?
Pack, A. M. (2008) · Seizure · doi:10.1016/j.seizure.2007.11.020 · Cited by 156
Beyenburg, S., Stavem, K., & Schmidt, D. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02299.x · Cited by 149
Self-citationA 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy
Kim, S. H., Lee, J. W., Choi, K., Chung, H. W., & Lee, H. W. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.11.007 · Cited by 143
Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies
Benedetti, M. S. (2000) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2000.tb00411.x · Cited by 138
Costa, J. N., Fareleira, F., Ascenção, R. M. S. E. S., Borges, M., Sampaio, C., & Carneiro, A. V. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03047.x · Cited by 138
Bragin, A., Benassi, S. K., Kheiri, F., & Engel, J. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02896.x · Cited by 137
Silbergleit, R., Lowenstein, D. H., Durkalski, V., CONWIT, R. A., & the Neurological Emergency Treatment Trials (NETT) Investigators (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03235.x · Cited by 133
Current position of phenobarbital in epilepsy and its future
Brodie, M. J., & Kwan, P. (2012) · Epilepsia · doi:10.1111/epi.12027 · Cited by 132
Trinka, E., Marson, A. G., Van Paesschen, W., Kälviäinen, R., Marovac, J., Duncan, B., Buyle, S., Hallström, Y., Hon, P., Muscas, G. C., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300376 · Cited by 121
The Long-Term Safety of Antiepileptic Drugs
Gaitatzis, A., & Sander, J. W. A. S. (2013) · CNS Drugs · doi:10.1007/s40263-013-0063-0 · Cited by 118
The treatment of depressive disorders in epilepsy: What all neurologists should know
Kanner, A. M. (2013) · Epilepsia · doi:10.1111/epi.12100 · Cited by 116
Marson, A. G., Appleton, R. E., Baker, G. A., Chadwick, D. W., Doughty, J., Eaton, B., Gamble, C. L., Jacoby, A., Shackley, P., Smith, D., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11370 · Cited by 110
New Developments in Antiepileptic Drug Resistance: An Integrative View
Schmidt, D., & Löscher, W. (2009) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2008.01289.x · Cited by 108
Self-citationCarbone, L. D., Johnson, K., Robbins, J. A., Larson, J. C., Curb, J. D., Watson, K. C., Gass, M. L. S., & LaCroix, A. Z. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091027 · Cited by 106
Issues related to development of antiepileptogenic therapies
Pitkänen, A., Nehlig, A., Brooks‐Kayal, A. R., Dudek, F. E., Friedman, D. J., Galanopoulou, A. S., Jensen, F. E., Kaminski, R. M., Kapur, J., Klitgaard, H., et al. (2013) · Epilepsia · doi:10.1111/epi.12297 · Cited by 99
Self-citationThe treatment of depression in patients with epilepsy A double-blind trial
Robertson, M. M., & Trimble, M. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90091-6 · Cited by 99
Lazzari, A. A., Dussault, P. M., Thakore‐James, M., GAGNON, D. R., Baker, E. H., Davis, S. A., & Houranieh, A. M. (2013) · Epilepsia · doi:10.1111/epi.12351 · Cited by 88
Integration of adult generated neurons during epileptogenesis
Zhao, C., & Overstreet‐Wadiche, L. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01632.x · Cited by 73
Berger, E. L. (2008) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31818ec5a0 · Cited by 70
The natural history of drug resistant epilepsy: epidemiologic considerations.
Hauser, W. A. (1992) · PubMed · Cited by 70
Safety and Tolerability of Antiepileptic Drug Treatment in Children with Epilepsy
Guerrini, R., Zaccara, G., la Marca, G., & Rosati, A. (2012) · Drug Safety · doi:10.2165/11630700-000000000-00000 · Cited by 60
Bonnett, L. J., Shukralla, A. A., Smith, C. T., Williamson, P. R., & Marson, A. G. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.222885 · Cited by 59
Perampanel—new promise for refractory epilepsy?
Löscher, W., & Schmidt, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.222 · Cited by 58
Self-citationDevelopment of new treatment approaches for epilepsy: Unmet needs and opportunities
French, J. A., White, H. S., Klitgaard, H., Holmes, G. L., Privitera, M., Cole, A. J., Quay, E., Wiebe, S., Schmidt, D., Porter, R. J., et al. (2013) · Epilepsia · doi:10.1111/epi.12294 · Cited by 57
Self-citationTreatment of Depression in Patients with Epilepsy
Noe, K., Locke, D. E. C., & Sirven, J. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0127-8 · Cited by 55
Identifying targets for preventing epilepsy using systems biology
Loeb, J. A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.041 · Cited by 53
Is antiepileptogenesis a realistic goal in clinical trials? Concerns and new horizons*
Schmidt, D. (2012) · Epileptic Disorders · doi:10.1684/epd.2012.0512 · Cited by 52
Self-citationThe epilepsies: Complex challenges needing complex solutions
Tejada, J., Costa, K. M., Bertti, P., & Garcia‐Cairasco, N. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.09.029 · Cited by 50
Kanner, A. M. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835ee579 · Cited by 50
Guerrini, R., Scerrati, M., Rubboli, G., Esposito, V., Colicchio, G., Cossu, M., Marras, C. E., Tassi, L., Tinuper, P., Canevini, M. P., et al. (2013) · Epilepsia · doi:10.1111/epi.12308 · Cited by 46
Systems biology, complexity, and the impact on antiepileptic drug discovery
Margineanu, D. G. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.08.029 · Cited by 45
Therapeutic Monitoring of Antiepileptic Drugs during Pregnancy and in the Postpartum Period
Adab, N. (2006) · CNS Drugs · doi:10.2165/00023210-200620100-00001 · Cited by 42
Risks of In Utero Exposure to Valproate
Meador, K. J., & Loring, D. W. (2013) · JAMA · doi:10.1001/jama.2013.4001 · Cited by 40
Natural Products in Epilepsy—the Present Situation and Perspectives for the Future
Ekstein, D., & Schachter, S. C. (2010) · Pharmaceuticals · doi:10.3390/ph3051426 · Cited by 39
Self-citationPerucca, E. (2012) · Epileptic Disorders · doi:10.1684/epd.2012.0511 · Cited by 37
Friedman, D. J., & French, J. A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70177-1 · Cited by 34
Strategies to prevent overtreatment with antiepileptic drugs in patients with epilepsy
Schmidt, D. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00186-9 · Cited by 29
Self-citationEpilepsy and driving: considerations on how eligibility should be decided
Lossius, R., Kinge, E., & Nakken, K. O. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01379.x · Cited by 21
Abou-Khalil, B. W., & Schmidt, D. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52899-5.00024-1 · Cited by 17
Self-citationEzogabine: A New Angle on Potassium Gates
Faught, E. (2011) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-11.3.75 · Cited by 14
Cited by
Molecular Targets of Cannabidiol in Neurological Disorders
Ibeas Bih, C., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 578
Diagnostic challenges in epilepsy: seizure under-reporting and seizure detection
Elger, C. E., & Hoppe, C. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30038-3 · Cited by 403
Clinical utility of EEG in diagnosing and monitoring epilepsy in adults
Tatum, W. O., Rubboli, G., Kaplan, P. W., Mirsatari, S. M., Radhakrishnan, K., Gloss, D., Caboclo, L. O., Drislane, F. W., Koutroumanidis, M., Schomer, D. L., et al. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.01.019 · Cited by 314
Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases
Anthony, D. P., Hegde, M., Shetty, S. S., Rafic, T., Mutalik, S., & Rao, B. S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119326 · Cited by 110
Hill, T., Coupland, C., Morriss, R., Arthur, A., Moore, M., & Hippisley-Cox, J. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0701-9 · Cited by 91
Metadata
- Authors
- Schmidt, D., & Schachter, S. C.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-02-28
- Volume
- 348
- Issue
- feb28 2
- Pages
- g254-g254
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2077008944
- Cited by
- 323
- References
- 114
- FWCI
- 22.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.